The Angiogenesis Therapeutic Agent Market encompasses pharmaceutical and biotech solutions designed to modulate the process of new blood vessel formation. These agents are primarily used to treat conditions such as cancer, age-related macular degeneration, and certain inflammatory diseases by inhibiting or stimulating angiogenesis. Their core functionalities include targeted delivery of biologics, small molecules, or gene… Angiogenesis Therapeutic Agent Market to Witness Huge Growth by 2033 weiterlesen